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Abstract
Background: D-ribose in cells and human serum participates in glycation of proteins resulting in
advanced glycation end products (AGEs) that affect cell metabolism and induce cell death.
However, the mechanism by which D-ribose-glycated proteins induce cell death is still unclear.
Results: Here, we incubated D-ribose with bovine serum albumin (BSA) and observed changes in
the intensity of fluorescence at 410 nm and 425 nm to monitor the formation of D-ribose-glycated
BSA. Comparing glycation of BSA with xylose (a control for furanose), glucose and fructose
(controls for pyranose), the rate of glycation with D-ribose was the most rapid. Protein intrinsic
fluorescence (335 nm), Nitroblue tetrazolium (NBT) assays and Western blotting with anti-AGEs
showed that glycation of BSA incubated with D-ribose occurred faster than for the other reducing
sugars. Protein intrinsic fluorescence showed marked conformational changes when BSA was
incubated with D-ribose. Importantly, observations with atomic force microscopy showed that D-
ribose-glycated BSA appeared in globular polymers. Furthermore, a fluorescent assay with
Thioflavin T (ThT) showed a remarkable increase in fluorescence at 485 nm in the presence of D-
ribose-glycated BSA. However, ThT fluorescence did not show the same marked increase in the
presence of xylose or glucose. This suggests that glycation with D-ribose induced BSA to aggregate
into globular amyloid-like deposits. As observed by Hoechst 33258 staining, 3-(4, 5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and cell counting kit-8 (CCK-8) assay, lactate
dehydrogenase (LDH) activity assay, flow cytometry using Annexin V and Propidium Iodide staining
and reactive oxygen species (ROS) measurements, the amyloid-like aggregation of glycated BSA
induced apoptosis in the neurotypic cell line SH-SY5Y.
Conclusion: Glycation with D-ribose induces BSA to misfold rapidly and form globular amyloid-
like aggregations which play an important role in cytotoxicity to neural cells.
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Background
Non-enzymatic glycation of proteins by reducing saccha-
rides such as glucose (glc) and ribose (rib) leads to the for-
mation of fructosamine [1] and advanced glycation end
products (AGEs) [2,3]. Among the reducing monosaccha-
rides, the role of glc in the glycation of proteins has been
widely studied, and is implicated in diabetes [4], cataracts
[5], renal failure [6], and other disorders [7]. It has
recently become clear that glycation is also involved in
physiological neurodegenerative diseases such as Alzhe-
imer's disease [8]. Glycation alters the biological activity
of proteins and their degradation processes. Protein cross-
linking by glycation results in the formation of detergent-
insoluble and protease-resistant aggregates. Therefore, the
study of AGEs has become one of the most important
areas of biomedical research today.
The glc-glycation process that gives rise to AGEs requires a
long time. Many reports indicate that glycation with glc
advances slowly and is associated with every fundamental
process in cellular metabolism [9-11]. Although a great
deal of work has been carried out on glycation of proteins
with glc, few research groups have attempted to investi-
gate the role of rib in glycation and its resulting effects on
cell metabolism. Compared with glc, rib is more active in
glycation of proteins and the formation of AGEs [12,13].
The role of D-rib in glycation and cross-linking of collagen
has been investigated in in vitro studies of the triggering of
skin ageing [14]. Luciano and colleagues (2008) prepared
proteins glycated with rib in a study of AGEs and their
effects on pancreatic islet beta-cells. Direct effects of AGEs
on cellular viability and related insulin secretion of beta-
cells resulting from their exposure to glycated serum by
incubation with rib have been evaluated. Results showed
reduced cellular proliferation with a corresponding
increase in cell necrosis and cell apoptosis rate in compar-
ison with untreated cells after 5 days of exposure to glyca-
tion conditions [15].
Further studies have shown that glycation reactions lead
to the production of reactive oxygen species (ROS), which
are harmful to cellular metabolism and cause cell damage
[16]. Consequently, considerable attention has been
given in recent years to studying the generation of
hydroxyl radicals from Amadori proteins, and inhibition
of hydroxyl radical damage [17]. As with glc-glycation,
glycation of proteins with rib also involves Amadori rear-
rangement and then production of AGEs. Therefore, some
research groups have employed glycation with rib instead
of glc as a model for investigating the mechanism by
which AGEs yield hydroxyl radicals and induce cell apop-
tosis or necrosis [15,17,18].
Most recently, formation of molten globule-like states has
been reported during the progression of glycation reac-
tions in vitro [19]. According to Dobson et al., globule-like
protein aggregations (pro-amyloid fibrils) are signifi-
cantly toxic to neurons [20-23]. However, the characteris-
tics and cytotoxicity of molten globule-like protein states
induced by glycation have not been clarified. There are no
reports in the literature showing that glycation with rib
can induce protein misfolding and aggregation in amy-
loid-like deposits.
Glycation of serum albumin has been widely studied in
recent years [1,15,24,25], and bovine serum albumin
(BSA) is commonly used as molecular model. Signifi-
cantly, Friedman and colleagues have reported neurotox-
icity for brain-penetrant serum albumin including BSA
[26,27]. This study is concerned with determining
whether glycation of BSA with D-rib in the short term (1–
7 days) results in globular amyloid-like aggregations that
are seriously toxic to neuroblast cells through apoptosis,
compared with other pyranose and furanose.
Results
BSA is rapidly glycated in the presence of ribose
To investigate whether glycation of a protein with rib is a
rapid process, we incubated BSA with rib, glc, xylose (xyl),
fructose (frc) or sucrose (non-reducing sugar, suc), and
monitored changes in the intensity of the fluorescence
(λex = 320 nm/λem = 410 nm; λex = 370 nm/λem = 425 nm)
that is commonly used to detect the formation of glycated
products [28-31]. Figure 1A illustrates changes in the rela-
tive emission intensities at 410 nm of BSA incubated with
D-rib. Of the monosaccharides tested, the fluorescence of
rib-glycated BSA increased most markedly with time and
had the shortest relaxation time (about one day). The
increase in the relative intensity (%) of the fluorescence
for rib-glycated BSA was the fastest with an increase of
16.37% per day during the incubation period (Figure 1B,
Table 1). The relative fluorescence intensity of xyl-glycated
BSA as a control for furanose for 7 days was ~51% of that
of rib-glycated BSA (indicated as 100%) and had a rela-
tively short relaxation time. However, changes in the flu-
orescent emission of BSA in the presence of glc and frc as
controls for pyranose were not significantly different
under the experimental conditions used here. BSA alone,
or in the presence of suc (non-reducing sugar) as a nega-
tive control, showed no significant changes in fluores-
cence. This suggests that furanose, especially rib, reacts
much more rapidly with BSA than pyranose in the pro-
duction of glycated products.
Glycation of BSA in the presence of rib at low concentra-
tions was also investigated (Figure 1B). A moderate
increase in emission intensity at 410 nm of glycated BSA
was observed in the presence of 0.1 M rib. This suggests
that glycation efficiency of BSA depends on the rib con-
centration.BMC Cell Biology 2009, 10:10 http://www.biomedcentral.com/1471-2121/10/10
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Similar results were observed when fluorescence at 425
nm was measured. As shown in Figure 1C, a rapid increase
in the relative fluorescent intensity of rib-glycated BSA was
also observed under the same conditions. This suggests
again that rib is more active in protein glycation than the
other reducing sugars used in this work.
To investigate further whether glycation was faster in the
presence of rib than other reducing sugars, we incubated
BSA with rib and analysed aliquots taken at different time
intervals by SDS-PAGE (Figure 2). Retardation of protein
bands was observed during the glycation of BSA in the
presence of rib. The increasing apparent molecular masses
of BSA during glycation probably resulted from bound
rib. Analysis using mass spectrometry showed that the dif-
ference in the molecular mass between rib-glycated BSA
(incubated for 7 days) and native BSA was 5,478 Da,
showing ~41 rib (133 Da each) molecules bound to BSA.
However, the retardation of BSA bands that had been
incubated with other reducing sugars was not so distinct
as that of BSA glycated with rib observed under the same
conditions. No significant band retardation was exhibited
with BSA alone or in the presence of suc which was used
as a negative control. These results demonstrate that BSA
is more vulnerable to rib glycation than to glycation with
the other sugars tested.
Formation of fructosamine during glycation of BSA with
rib under experimental conditions, was evaluated using
NBT assays, carried out as shown in Figure 3A. The con-
centration of fructosamine in the rib-glycated BSA solu-
tion increased markedly in the initial 24 hour (h) period,
showing a more rapid glycation procedure for rib than
other monosaccharides. This indicates again that rib is the
most active sugar in the glycation of BSA under the exper-
imental conditions used.
To confirm whether AGEs were formed during glycation
with rib, a monoclonal antibody (anti-AGEs) which rec-
ognizes the N-(carboxymethyl) lysine protein adduct of a
major immunological epitope in proteins modified with
AGEs [32] was used in Western blotting. Results showed
that AGEs formed at the initial stages of glycation, and
increased markedly on the first day of BSA incubation
with rib (Figure 3B). However, AGEs were not detected
with BSA alone (Figure 3C) or glycated with the other
reducing sugars under the same conditions (data not
shown).
Conformational changes of BSA during glycation in the 
presence of ribose
First, we attempted to detect whether the secondary struc-
ture of BSA was changed during glycation. However, no
significant changes in CD spectra of the protein before
and after glycation were detected. That is to say, both α-
helix and β-sheet secondary structures (Additional file 1)
were not markedly changed by glycation. It appears that
changes in the conformation of rib-glycated BSA do not
occur in secondary structures, but rather in higher order
structures.
Intrinsic fluorescence is commonly used to study confor-
mational changes of a protein in solution [33-35]. As
shown in Figure 4, the intrinsic fluorescence of BSA
decreased markedly during incubation with rib. Over the
period of the 7 day incubation, the intensity of the intrin-
sic emission of rib-glycated BSA decreased by 50% com-
pared with that of BSA alone as a control (100%).
Table 1: Relaxation time of relative increase in intrinsic fluorescence intensity of BSA with different monosaccharides
λex 320 nm/λem 410 nm λex 280 nm/λem 335 nm
Relaxation time (d) Increase (%) Decrease (%)
BSA - - -
BSA+frc - - -
BSA+glc - - -
BSA+suc - - -
BSA+xyl 2 8.4 5.89
BSA+rib 1 16.37 7.43
BSA+0.1M rib 3 2.48 1.98BMC Cell Biology 2009, 10:10 http://www.biomedcentral.com/1471-2121/10/10
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According to Swamy [36], a decrease in the intrinsic fluo-
rescence results from exposure of tryptophanyl residues to
solvent molecules that collide with fluorophores and con-
sume the fluorescence energy. This suggests that the
molecular conformation of rib-glycated BSA changes dur-
ing glycation.
Furthermore, we examined conformational changes of
rib-glycated BSA using digestion with trypsin. We took
aliquots at different time intervals during the glycation
process for trypsin digestion (Figure 5). BSA (66 kDa) gly-
cated with reducing monosaccharides released 4 common
peptide fragments -a, -b, -c, and -d with apparent molecu-
lar masses of 57.0, 41.1, 36.7 and 27.2 kDa, respectively,
in the presence of trypsin. Significantly, after incubation
for 5 days, peptides -a and -b were not detected when rib-
glycated BSA was incubated with trypsin. After incubation
for 7 days, only peptide -a was observed. The four peptide
fragments, however, were present on the SDS-PAGE for
frc-, glc- and xyl-glycated BSA under the same conditions.
In the presence of trypsin, BSA alone or with suc as a con-
trol released the same peptide fragments from day 1 to day
7. This suggests that the difference of the cleavage on BSA
in the presence of trypsin arises from protein polymeriza-
tion during glycation with rib. Maybe lys residues at the
cleavage sites were blocked by glycation or the conforma-
tional rearrangement following increasing glycation by
rib progressively uncovered the other cleavage sites while
hindering accessibility to the a cleavage site.
Globule aggregates of D-ribose-glycated BSA
To clarify whether blockage of trypsin digestion resulted
from protein polymerization, we employed atomic force
microscopy (AFM) to observe particle size changes of rib-
glycated BSA during glycation. As shown in Figure 6, the
particle size of rib-glycated BSA started to increase from
day 5 of the incubation period, exhibiting protein polym-
erization. A significant increase in particle size could be
observed from day 6 of the incubation period. BSA gly-
cated with the other monosaccharides as mentioned
above showed no significant polymerization under these
experimental conditions (Table 2). BSA alone (Additional
file 2) or with suc as a control maintained constant parti-
cle size as determined by AFM. These results demonstrate
that glycation with rib induces BSA to polymerize and
form globular polymers.
What are the characteristics of BSA polymers? To answer
this question, we added Thioflavin T (ThT) a fluorescent
reagent to test whether the polymers are amyloid-like
aggregates (Figure 7). Fluorescence of ThT at 485 nm sig-
nificantly increased in the presence of BSA incubated with
rib for 4 days. Fluorescence intensity increased 170% rel-
ative to BSA alone as a control. However, BSA incubated
with the other reducing monosaccharides frc, glc and xyl
Time course of changes in the fluorescence of BSA incubated  with different saccharides Figure 1
Time course of changes in the fluorescence of BSA 
incubated with different saccharides. BSA (final concen-
tration 150 μM) in the presence of D-ribose (rib, final con-
centration 1 M) was kept at 37°C in Tris-HCl buffer (pH 7.4). 
BSA or rib alone was used as a control. (A) Aliquots were 
taken for measurements of fluorescence spectra (λex = 320 
nm) at different time intervals. (B) Time course of changes in 
the maximal fluorescent intensity (λex320 nm; λem410 nm) of 
BSA incubated with rib, glucose (glc), fructose (frc), xylose 
(xyl) and sucrose (suc). (C) Changes in fluorescence at λex 
370 nm; λem 425 nm were also detected under the same con-
ditions.
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(including non-reducing sugar suc as a control) showed
no significant changes in ThT fluorescence under our
experimental conditions.
Cytotoxicity of ribose-glycated BSA and its putative 
mechanism
Having determined that rib-glycated BSA polymers were
globular amyloid-like aggregates, we were concerned
about the cytotoxicity of these aggregates, and thus tested
the cytotoxicity of the glycated protein in cell culture.
Morphological evaluation of cell line SH-SY5Y was carried
out to investigate effect of rib-glycated BSA on neural cells.
As shown in Figure 8, rib-glycated BSA markedly induced
axonal atrophy, and cells became spherical with con-
densed nuclei, as visualized by Hoechst 33258 staining
under fluorescence microscopy. BSA alone (or incubated
with suc), and glycated BSA with the other reducing mon-
osaccharides, did not show axonal atrophy and cell con-
10% SDS-PAGE of the products of BSA incubation with dif- ferent saccharides Figure 2
10% SDS-PAGE of the products of BSA incubation 
with different saccharides. Incubation conditions were as 
in Figure 1, except that aliquots were taken from incubation 
mixtures at different time intervals for SDS-PAGE electro-
phoresis.
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Fructosamine assay of the products of BSA incubation with  different saccharides and Western blots of D-ribose-glycated  BSA Figure 3
Fructosamine assay of the products of BSA incuba-
tion with different saccharides and Western blots of 
D-ribose-glycated BSA. Incubation conditions were as in 
Figure 1, except that aliquots were taken from incubation 
mixtures for NBT assays at different time intervals (A). 
Western blotting of D-rib-glycated BSA with anti-AGEs (B); 
and BSA in the absence of sugar (control) (C).
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densation under the experimental conditions used (data
not shown). This suggests that rib-glycated BSA is strongly
cytotoxic to neurons in cell culture.
The effect of rib-glycated BSA on the viability of SH-SY5Y
cells was then examined by using MTT and CCK-8 assays
[37,38]. As shown in Figure 9A, the number of viable cells
decreased significantly after incubation with rib-glycated
BSA for 8 h, whereas a significant decrease in cell viability
was not observed in the presence of BSA glycated with glc,
frc and xyl or BSA alone. Moreover, decrease in cell viabil-
ity induced by rib-glycated BSA occurred in a concentra-
tion-dependent manner; rib-glycated BSA formed after 3
or more days of incubation with rib showing cytotoxicity
to cells exposed to rib-glycated BSA for at least 8 h (Figures
9B, C).
In order to determine whether the neurotoxicity of rib-gly-
cated BSA involved an apoptotic pathway, we used flow
cytometry to examine the effects of rib-glycated BSA on
SH-SY5Y cells (Figure 10). Cells that were incubated with
rib-glycated BSA for 8 h and then treated with the dyes
Annexin-V (AV, an indicator of apoptosis) and propidium
iodide (PI, an RNA dye) [39] showed a clear increase in
both LR (apoptotic) and UR (late apoptosis, necrosis) SH-
SY5Y cell populations after 24 h. After 8 h of exposure to
rib glycation conditions, there was a corresponding
increase in cell apoptosis (+21.22%) and late apoptosis/
necrosis (+63.29%) rates in comparison with untreated
cells.
To further confirm that SH-SY5Y cells were damaged in
the presence of rib-glycated BSA, an assay system for
quantifying the release of LDH from cells was carried out
as shown in Figures 11 and 12A. Ribose-glycated BSA at
concentrations of 5–8 μM triggered dose-dependent cyto-
toxicity of cells incubated for 8 h. However, cytotoxicity of
BSA alone or glycated with the other reducing sugars was
not detected under the same conditions (data not shown).
The significant increase in plasma membrane permeabil-
Changes in the intrinsic fluorescence of BSA incubated with  different saccharides Figure 4
Changes in the intrinsic fluorescence of BSA incu-
bated with different saccharides. Incubation conditions 
were as in Figure 1, except that aliquots were taken from 
incubation mixtures for measurements of the intrinsic fluo-
rescence (λex 280 nm; λem 335 nm) at different time intervals.
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ity detected by LDH assay indicates damage of SH-SY5Y
cells exposed to rib-glycated BSA.
To clarify whether free radicals had a role in causing
lesions in SH-SY5Y cells exposed to rib-glycated BSA, we
measured intracellular levels of ROS. As shown in Figure
12B, the intracellular level of ROS increased significantly
when cells were exposed to rib-glycated protein compared
with rib or BSA alone. This suggests that the cell death
induced by globular amyloid-like aggregation of rib-gly-
cated BSA is related to the intracellular ROS pathway.
Discussion
Glycation is a stepwise process that begins with a nucle-
ophilic addition reaction between a free amino group of a
protein and a carbonyl group from a reducing sugar, form-
ing a reversible intermediate product (Schiff's base). The
Schiff's base can turn into a stable ketoamine by an Ama-
dori rearrangement [1]. The next step is the formation of
numerous intermediary products, some of which are very
reactive. The final step consists of crosslink formation
between products in which heterogeneous structures
called advanced glycation end products (AGEs) are
formed [40]. Transformation of Schiff's bases to relatively
stable yet reversible ketoamines is slow and requires a
long time [11,41], but AGEs are formed rapidly from
ketoamines [13,42]. In this work, as can be seen in Figure
3, the glycation of BSA with rib results in rapid production
of AGEs, almost within 24 h under the experimental con-
ditions used. The speed of conversion from Schiff's bases
to stable ketoamines for BSA exposed to rib during glyca-
tion was much faster than for BSA exposed to glc. That is
to say, the glycation speed of rib with BSA was the most
rapid of the reducing sugars used in this work.
NBT assays, changes in fluorescence (410 nm and 425
nm) and protein intrinsic fluorescence (335 nm) showed
that the furanoses rib and xyl are much more active in the
Table 2: Diameter of BSA glycated with different 
monosaccharides.
Samples Particle size (nm)
3 d 7 d
BSA+rib 4.146 ± 1.745 11.378 ± 4.758
BSA+suc 2.917 ± 0.882 3.028 ± 2.550
BSA+frc 3.010 ± 1.951 3.695 ± 2.184
BSA+glc 2.041 ± 1.412 2.481 ± 1.576
BSA+xyl 3.141 ± 2.278 3.521 ± 2.323
BSA 3.208 ± 1.257 2.385 ± 0.799
rib 1.434 ± 1.064 1.052 ± 0.696
Observation of BSA incubated with ribose by atomic force  microscopy Figure 6
Observation of BSA incubated with ribose by atomic 
force microscopy. Incubation conditions were as in Figure 
1, except that aliquots were taken from incubation mixtures 
at different time intervals for observation by AFM (A). The 
scale bar equals 1 μm. The horizontal diameter at half height 
was shown (B).
Changes in the Thioflavin T fluorescence of BSA treated with  different saccharides Figure 7
Changes in the Thioflavin T fluorescence of BSA 
treated with different saccharides. Thioflavin T (30 μM 
final concentration) was mixed with samples of BSA in differ-
ent saccharide solutions for different time intervals. The fluo-
rescence intensity of Thioflavin T was recorded (λex 450 nm; 
λem 485 nm). Kinetics of the increase in fluorescence emis-
sion of ThT with glycated BSA are shown.
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glycation of BSA than the pyranoses glc and frc. Of the five
sugars, rib is the most active. Glc exists in solution as an
intramolecular hemiacetal in which the free hydroxyl
group at C-5 has reacted with the aldehydic C-1, rendering
the latter asymmetric and giving rise to stereoisomers. The
six-membered aldopyranose ring is much more stable
than the aldofuranose five-membered ring because the
pentose ring for rib and xyl is not planar but occurs in one
of a variety of conformations generally described as
"puckered" [43]. The unstable aldofuranose ring is vulner-
able to reactions with amino groups. This may be one rea-
son why furanoses are more reactive in glycation than
pyranoses. The difference in glycation activity of rib and
xyl is probably due to different configurations of the
hydroxyl group at C-3.
Phase contrast microscope image of cells treated with gly- cated BSA Figure 8
Phase contrast microscope image of cells treated 
with glycated BSA. SH-SY5Y cells were imaged after incu-
bation with rib-glycated BSA (20 μM, 3-day sample) for 8 h. 
Normal cells were used as controls. Cells were visualized by 
inverted contrast microscopy. Statistics of apoptotic cells 
was also shown. Bar = 25 μm.
Cell viability measured by CCK-8 and MTT assays Figure 9
Cell viability measured by CCK-8 and MTT assays. 
BSA alone or incubated with different saccharides at 37°C 
for 3 days, was added to SH-SY5Y cells for 8 h and cell viabil-
ity was measured using the CCK-8 assay at 8 h, 24 h, and 48 
h after sample addition (A). BSA incubated with 0.1 M rib (B) 
or 1 M rib (C) for 0–7 days was added to SH-SY5Y cells for 8 
h and cell viability was measured using the MTT assay at 8 h, 
24 h, and 48 h after sample addition.
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BSA contains two tryptophanyl residues (Trp 135 and Trp
214) that are largely responsible for the protein intrinsic
fluorescence (335 nm). As shown in Figures 1 and 4,
intrinsic fluorescence decreases markedly while emission
at 410 nm and 425 nm increases as incubation period
lengthens. Fluorescence at 410 nm and 425 nm reflects
the formation of AGEs, and thus it is reasonable for rib-
glycated BSA to show a marked increase in emission inten-
sity [44]. The decrease in intrinsic fluorescence is related
to a conformational change in BSA. This results from
exposure of Trp 135 and Trp 214 residues to solvent mol-
ecules which have higher colliding frequency with
exposed tryptophanyl residues during glycation. This sug-
gests that the molecular conformation of BSA becomes
more random during its reaction with rib.
Changes observed in fluorescence at 410 nm and 425 nm
and intrinsic fluorescence (335 nm) are somewhat differ-
Ribose-glycated BSA induces SH-SY5Y cell apoptosis Figure 10
Ribose-glycated BSA induces SH-SY5Y cell apoptosis. 
Flow cytometric analysis of SH-SY5Y cells 24 h after treat-
ment with rib-glycated BSA for 8 h (D). Normal cells (A), rib 
(B), BSA (C) were also shown.
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D
Cytotoxicity detection of ribose-glycated BSA in SH-SY5Y  cells Figure 11
Cytotoxicity detection of ribose-glycated BSA in SH-
SY5Y cells. Ribose-glycated BSA of different concentrations 
was added to SH-SY5Y cells. The LDH activity and CCK-8 
assays were used to measure the cytotoxicity of samples 
after incubation for 4 h (A), 8 h (B), 12 h (C), and 24 h (D).
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ent to results observed from Western blotting with AGE-
antibodies. As shown in Table 1, the rate of formation of
AGEs from rib-glycated BSA was significantly faster than
that detected by fluorescence. Anti-AGEs recognize N$-car-
boxymethyllysine(CML)-protein adducts as epitopes
[32,45]. Fluorescence, however, is not only related to the
characteristic of the fluorophore (the formed glycation
product), but also to protein conformational change. The
image of rib-glycated BSA can be seen on the mica surface
under AFM (Figure 6A). Formation of rib-glycated BSA
polymers occurred from day 5 of the incubation period.
That is to say, protein conformational changes followed
after the formation of AGEs from rib-glycated BSA.
CD spectra did not show distinct changes after glycation
of BSA with rib (Additional File 1), i.e. secondary struc-
tures of rib-glycated BSA did not change relative to control
native BSA. Results from fluorescence observations
showed that BSA did undergo changes in molecular con-
formation. Although changes in Trp fluorescence are
strictly symptomatic of local changes in the tryptophanyl
residue microenvironment, they are usually also associ-
ated with larger structural rearrangements of the peptide
chains [46]. This suggests that conformational changes
that occurred were protein polymerization under the
experimental conditions. This theory was confirmed using
AFM. BSA molecules polymerized into globular aggre-
gates in the presence of rib from day 5 of the incubation
period (Figure 6). According to Sattarahmady, glycation
leads to formation of molten protein globules [19]. We
hypothesize that molten globules are probably prefibrils
with some characteristic of amyloid-like aggregations.
To investigate whether rib-glycated BSA forms amyloid-
like aggregations, we measured the fluorescence at 485
nm of ThT incubated with the glycated product (Figure 7),
as ThT fluorescence is commonly used to detect the for-
mation of amyloid-like aggregations [46-51]. Our results
show that emission intensity was markedly increased dur-
ing the rib-glycation process. According to recent studies,
ThT has been found to bind to proteins in the nonfibrillar
state (oligomers), probably because of the open structure
of these proteins. Some protein molten globules are posi-
tive in ThT fluorescence [46,49]. Thus, we thought that
polymers of rib-glycated BSA are present as amyloid-like
aggregations. In other words, ribosylated BSA is probably
in molten globules with amyloid-like characteristics. On
this point, fibrils might arise when BSA is exposed to rib
for a longer time, which needs further investigation.
Globular-like amyloid protein aggregations are known to
have fatal neurotoxicity [52]. Previous work in our lab
showed that the globular-like amyloid tau protein
induced by formaldehyde has significant cytotoxicity to
SH-SY5Y cells and HEK-293 cells [53-55]. Western blot-
ting results in Figure 3 show that the toxicity of rib-gly-
cated BSA is related to AGEs. Xyl-glycated BSA did not
show significant cytotoxicity to SH-SY5Y cells because lit-
tle AGEs were formed from xyl-glycated products under
these experimental conditions, i.e. it is AGEs or interme-
diate products of rib-glycated BSA that act as cytotoxic
agents to induce SH-SY5Y cell death. Thus, rib-AGEs were
used rather than rib-glycated BSA in following tests.
As illustrated in Figures 9 and 11, exposure to rib-AGEs
inhibited SH-SY5Y cell viability and induced cytotoxity.
LDH assay and measurement of ROS in SH-SY5Y Figure 12
LDH assay and measurement of ROS in SH-SY5Y. 
Rib-glycated BSA of different concentrations was added to 
SH-SY5Y cells for different lengths of time, then LDH activity 
was measured using a cytotoxicity detection kit (Roche, 
Switzerland) (A). The ROS level of cells was measured 24 h 
after the addition of samples (B).
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As described by Yamagishi and colleagues [56], AGEs aris-
ing from glc-glycated proteins lead to cell death via apop-
tosis. Results from LDH assays (Figure 12A) showed that
the LD50 of rib-glycated BSA for SH-SY5Y cells was approx-
imately 5 μM, similar to that obtained for the amyloid-
like tau protein (10 μM) [54]. On the basis of the follow-
ing observations we conclude that rib-glycated BSA
induced SH-SY5Y cell death via an apoptotic process. (1)
SH-SY5Y cells showed neurite atrophy and became spher-
ical with condensed nuclei in the presence of rib-AGEs.
(2) CCK-8, MTT and LDH assays indicated that rib-AGEs
decreased the viability of SH-SY5Y cells and induced cell
cytotoxicity. (3) flow cytometry analysis of Annexin V/PI
confirmed that apoptosis was induced by rib-AGEs.
Exposure to rib-AGEs induced a marked increase in intra-
cellular levels of ROS in SH-SY5Y cells (Figure 12B). This
suggests a correlation between exposure to rib-AGEs and
production of ROS in the cells. Here we propose a puta-
tive mechanism (Figure 13) for the apoptosis of SH-SY5Y
cells induced by rib-glycated BSA. Glycation of BSA with
rib induces protein misfolding and results in the forma-
tion of amyloid-like aggregations (molten globules) with
high cytotoxicity that trigger cell death by the activation of
cellular signalling cascades [57].
A number of issues require further explanation. Firstly gly-
cated BSA was prepared using a high concentration (1 M)
of reducing monosaccharides. This is common to proto-
cols used in many laboratories [13,17,19,44]. At such a
high concentration of reducing sugars, it is possible to
clarify which monosaccharide is most active in protein
glycation and has the strongest cytotoxicity. Here we have
established a useful model for preparing rib-glycated pro-
teins which can be used for preparing many other glycated
proteins readily, rapidly and repeatedly in the presence of
rib under these experimental conditions.
Secondly, rib is found in all living cells and on average,
the body contains about 16 mg of rib per litre of blood
(~100 μM), i.e. a roughly ten-fold lower level than that of
blood glc. Ribose exists in the cerebrospinal fluid and
Seuffer has determined the concentration (0.01–0.1 mM)
[58]. The level of rib-glycated protein in blood is still
unknown because of its relatively low concentration in
human blood. The amount of glc-glycated albumin and
hemoglobin products in the blood is known, but so far
there is no successful method for identifying whether gly-
cated proteins are coupled with rib or glc in blood. How-
ever, rib-glycated BSA is strongly toxic to neuroblast cells,
with a very low LD50 (~5 μM glycated BSA). The level of
rib in the blood (~100 μM) is about 20 times higher than
the LD50 of its glycated protein. Although complications
resulting from the rib-glycated protein have not yet been
clarified, attention should be paid to the effects of blood
rib when the level is markedly elevated.
Thirdly, as mentioned above, rib-glycated BSA was the
most toxic of the pyranose- or furanose-glycated BSA
tested to human neuroblast cells (SH-SY5Y). Ribose is of
vital importance to many activities of the cell and pro-
vides a backbone for synthesising the most important
molecules in the body, such as ATP, the "energy currency"
all cells need to function normally. In humans, it is syn-
thesized from glc and can also be used to make glc. This
monosaccharide is active and rapidly consumed. Thus far,
no evidence of complications resulting from rib-glycation
Putative mechanism of apoptosis of SH-SY5Y cells induced by  rib-glycated BSA Figure 13
Putative mechanism of apoptosis of SH-SY5Y cells 
induced by rib-glycated BSA. Glycation of BSA with rib 
induces protein misfolding and results in the formation of 
amyloid-like aggregations with high cytotoxicity that trigger 
cell death by the activation of cellular signalling cascades.BMC Cell Biology 2009, 10:10 http://www.biomedcentral.com/1471-2121/10/10
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have been presented. In fact, rib has been used as a nutri-
ent energy supply.
Finally, as shown in further experiments (unpublished
data), rib-glycated BSA is not only toxic to SH-SY5Y cells,
but is also toxic to BV2, a glia cell line. Ribose exists both
within and outside cells, and thus this monosaccharide
has the opportunity to glycate both intracellular and
extracellular proteins. The glycated products may be
harmful to cells and lead to damage of some important
cell types such as neurons and glia in the central nerve sys-
tem. For this reason, several native proteins were reported
to protect nerve cells from amyloid cytotoxicity, for exam-
ple, butyrylcholinesterase can inversely associate with the
soluble Aβ conformers and delay the onset and decrease
the rate of Aβ fibril formation in vitro [59]. However,
whether rib-glycation is related to complications such as
neurodegeneration requires further investigation.
Conclusion
Here we investigated the effect of D-ribose on protein mis-
folding and aggregation. Compared with other monosac-
charides, D-ribose is rapid in glycating BSA, and can
induce protein misfolding and aggregation, as observed
by fluorescence measurements, leading to the formation
of amyloid-like deposits that appeared as densely staining
granules under atomic force microscopy, and bound the
amyloid-specific dye thioflavin T. The amyloid-like aggre-
gates (molten globules) of BSA were observed to induce
apoptosis in neurotypic SH-SY5Y cells as stained by
Hoechst 33258, MTT and CCK-8 assay, LDH activity
assay, and flow cytometry using Annexin V and Propid-
ium Iodide staining, as well as ROS measurements. These
results suggest that D-ribose may play an important role
in AGE-related diseases.
Methods
Materials
Reducing monosaccharides employed in this work such as
pyranoses (glc, frc), furanoses (rib and xyl), non-reducing
disaccharides suc, and trypsin were from Amresco (USA).
Bovine serum albumin (BSA) and thioflavine T came from
Sigma (USA) and Aldrich (USA). Other chemicals were of
analytical grade.
Glycation of BSA
a. Preparation
BSA was dissolved in 20 mM Tris-HCl (pH 7.4) to yield a
stock solution of 20 mg/ml. This solution was then resus-
pended with rib prepared in Tris-HCl (pH 7.4) to a final
concentration of 10 mg/ml BSA and 0.1 M or 1 M mon-
osaccharide. BSA alone and in the presence of frc, glc, xyl
or suc was used as a control. Reaction mixtures were incu-
bated at 37°C for 0 to 7 days. All solutions were filtered
with 0.22 μm membranes (Millipore, USA).
b. SDS-PAGE
Aliquots of glycated protein samples were subjected to
SDS-PAGE. For the digestion experiment, BSA (final conc.
0.5 mg/ml) and trypsin (final conc. 0.5 mg/ml) were
mixed in Tris-HCl buffer (pH 7.4) to give a volume of 100
μl, and incubated at 37°C for 1 h. Aliquots were subjected
to electrophoresis using Bio-Rad (USA) electrophoresis
equipment.
c. Nitroblue tetrazolium (NBT) assay
For NBT assay, we followed a published method [25,60]
with the following modifications. 200 μl of 0.75 mM NBT
(Amresco, USA) was added to a 96-well microplate along
with 10 μl of the unknown sample or standard. The kinet-
ics for reduction of the dye by fructosamine groups (0.1 M
carbonate buffer, pH 10.35) was measured at 540 nm
using a MK3 microplate reader (Thermo, USA) after incu-
bating for 30 min at 37°C. Standard curves were gener-
ated by addition of 10 μl of 1-deoxy-1-morpholino-D-
fructose (1-DMF, Sigma, USA). Fructosamine formation
was monitored by comparison to standard curves (R2 >
0.99).
d. Western blotting
Aliquots of BSA incubated with rib for different durations
were subjected to electrophoresis. The proteins were then
transferred onto PVDF membranes, and probed with anti-
AGEs (dilution = 1:1000, 6D12, Wako, Osaka, Japan) fol-
lowed by goat anti-mouse horseradish peroxidase (HRP)
(KPL, Gaithersburg, Maryland, USA) at a dilution of
1:2000. Immunoreactive bands were visualized using
enhanced chemiluminescence (Pierce, USA).
Fluorescence measurements
Fluorescence of the advanced glycated end-products was
monitored on an F-4500 fluorophotometer (Hitachi,
Japan). Wavelengths (λex370 nm/λem425 nm; λex320 nm/
λem410 nm) were employed [24]. Desired final protein
concentration was 0.1 mg/ml (1.5 μM). Protein intrinsic
fluorescence at 335 nm was also measured by excitation at
280 nm. Thioflavin T (ThT, 30 μM), commonly used to
detect protein aggregations, was added to glycated BSA
(1.5 μM) to investigate whether any amyloid-like deposits
formed at 37°C. The fluorescence of ThT (λex450 nm/
λem485 nm) was measured at 25°C with a bandwidth of
1.5 nm. Changes in emission intensity (%) per day are
presented as ratios.
Circular dichroism (CD) spectropolarimetry measurements
CD spectra were recorded using a Jasco J-720 CD spec-
trometer (Japan). The spectra were measured in 1 mm
pathlengths of a quartz cuvette, and data were scanned
from 190 nm to 260 nm at 1 nm intervals. The final pro-
tein concentration was 1 mg/ml (15 μM). The bandwidth
was set at 1 nm (25°C). Baselines of the spectra were cal-BMC Cell Biology 2009, 10:10 http://www.biomedcentral.com/1471-2121/10/10
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ibrated using the spectrum of the buffer measured under
identical conditions. All experiments were repeated 10
times and averaged. The background of the corresponding
buffers without protein or rib was subtracted for all sam-
ples.
Atomic Force Microscope (AFM) measurements
Protein samples were diluted using Tris-HCl buffer (pH
7.4) and 10 μl of BSA (10 μg) was dropped onto the mica
surface and left for 5 min at room temperature before dry-
ing with nitrogen gas. The mica diaphragm was rinsed 20
times with ultrapurified water and dried with nitrogen gas
before observation under the atomic force microscope
(Mutiplemode-I, Digital Instruments, USA). The horizon-
tal diameter at half height of a particle (globular protein)
was measured and data were analyzed using Nanoscope
6.11r1 software (USA).
Cell culture
SH-SY5Y cells were cultured in Dulbecco's modified
Eagle's medium supplemented with 100 IU/ml penicillin
and 100 μg/ml streptomycin at 37°C in a humidified 5%
CO2 incubator as described [61]. The medium contained
10% fetal bovine serum. Cells were grown to 70–80%
confluence in 25 mm diameter dishes and fed every
fourth day. For all experiments, the culture medium was
replaced with serum-free medium before the addition of
the glycated protein. Cells were incubated with the sam-
ples (glycated BSA with each monosaccharide) (20 μM)
for 8 h. After that, medium was changed to DMEM con-
taining 10% fetal bovine serum.
Cell viability test
As described by Mayo and Tominaga [37,38], viability was
assessed using the 3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) test or cell counting
kit-8 (CCK-8). MTT and CCK-8 were from Beyotime
(China).
a. MTT assay
SH-SY5Y cells were seeded on a 96-well plate at a concen-
tration of 105cells per well and either exposed or not-
exposed to the glycated protein (20 μM) for 8 h. The cul-
ture media was then changed to DMEM with 10% fetal
bovine serum. 50 μl MTT (final concentration 0.5 mg/ml)
were added at 8, 24, and 48 h, respectively, after adding
the glycated protein. Plates were incubated at 37°C for 4
h, and then the assay was stopped by replacement of the
MTT-containing medium with 150 μl dimethysulfoxide
(DMSO) and the absorbance at 540 nm was recorded.
Absorbance measurements were recorded using a Multi-
scan Mk3 (Thermo Electron Corporation, USA).
b. CCK-8 assay
SH-SY5Y cells were seeded on a 96-well plate at a concen-
tration of 105cells per well and either exposed or not-
exposed to the glycated protein (20 μM) for 8 h. The cul-
ture media was then changed to DMEM with 10% fetal
bovine serum. The CCK-8 reagent were added at 8, 24,
and 48 h, respectively, after adding the glycated protein.
Plates were incubated at 37°C for 1 h and the absorbance
at 450 nm was recorded.
Cytotoxicity Detection
LDH cytotoxicity assays were performed according to the
manufacturer's protocol (Roche, Switzerland). This color-
imetric assay quantifies activity of LDH released from the
cytosol of damaged cells into the supernatant and thus
serves to quantify cell death [62,63].
Measurement of intracellular ROS
The level of cytosolic ROS was measured by DCFH-DA
(Beyotime, China) as described [64]. Briefly, SH-SY5Y
cells were grown in a 24-well plate and incubated with rib,
BSA, and rib-glycated BSA for 8 h. Normal cells were used
as controls. Cells were washed with PBS and incubated
with DCFH-DA for 30 min. DCFH-DA was initially non-
fluorescent and was converted by oxidation to the fluores-
cent molecule DCFH (λex485 nm/λem538 nm). DCFH was
then quantified using a CytoFluor Multi-well Plate Reader
(Fluoroskan Ascent, Thermo Lab Systerms, USA).
Flow cytometric analysis
Cells undergoing apoptosis were detected by double stain-
ing with Annexin V-FITC/PI in the dark according to the
manufacturer's instructions [39]. Cells attached to Petri
dishes were harvested with 0.25% trypsin and washed
twice with cold PBS. Cell pellets were suspended in 1×
binding buffer (10 mM HEPES/NaOH, pH 7.4, 140 mM
NaCl, 2.5 mM CaCl2) at a concentration of 1 × 106 cells/
ml. Then the cells were incubated with Annexin V-FITC
and propidium iodide (PI) for 15 min (22–25°C) in the
dark. The stained cells were immediately analyzed by flow
cytometry (FAC Svantage SE, USA). Each measurement
was carried out in at least triplicate.
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